duloxetine hydrochloride has been researched along with Parkinsonian Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gee, LE; Kaszuba, BC; Pilitsis, JG; Shin, DS; Walling, I | 1 |
| Baralatei, FT; Lauterbach, EC | 1 |
2 other study(ies) available for duloxetine hydrochloride and Parkinsonian Disorders
| Article | Year |
|---|---|
Effects of subthalamic deep brain stimulation with duloxetine on mechanical and thermal thresholds in 6OHDA lesioned rats.
Topics: Analgesics; Animals; Antiparkinson Agents; Combined Modality Therapy; Deep Brain Stimulation; Duloxetine Hydrochloride; Hot Temperature; Hyperalgesia; Male; Oxidopamine; Pain Threshold; Parkinsonian Disorders; Rats, Sprague-Dawley; Serotonin and Noradrenaline Reuptake Inhibitors; Subthalamic Nucleus; Touch | 2017 |
Switching to duloxetine remits ziprasidone - associated urinary incontinence and improves neuropsychiatric behavior in dementia: possible relationship of incontinence to 5HT2 receptor blockade.
Topics: Aged, 80 and over; Alzheimer Disease; Dementia, Vascular; Duloxetine Hydrochloride; Humans; Male; Parkinsonian Disorders; Piperazines; Receptors, Serotonin, 5-HT2; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Thiazoles; Thiophenes; Urinary Incontinence | 2009 |